Hong Kong has a unique regulatory system, the MDACS (Medical Device Administrative Control System). Unlike the NMPA registration in China, the listing of medical devices in Hong Kong is currently voluntary.
Since 06.11.2019, this voluntary listing in Hong Kong has become much more attractive tooverseas medical device manufacturers because with the Hong Kong listing, foreign manufacturers will also be permitted to sell into Hong Kong-owned healthcare institutions in the Greater Bay Area:
- University of Hong Kong-Shenzhen Hospital
- Modern Hospital Guangzhou
- Guangzhou United Family Hospital
- C-MER (Zhuhai) Dennis Lam Eye Hospital
- Zhongshan Chenxinghai Hospital
- The First Affiliated Hospital, Sun Yat-sen University
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University
- Nanfang Hospital of Southern Medical University
- Guangdong Provincial People's Hospital
- Guangzhou First People’s Hospital
- Clifford Hospital
- C-MER (Guangzhou) Dennis Lam Eye Hospital
- Shenzhen Qianhai Shekou Free Trade Zone Hospital
- Shenzhen Hyzen Hospital
- C-MER (Shenzhen) Dennis Lam Eye Hospital
- Zhuhai Hengqin Hospital
- Foshan Fosun Chancheng Hospital
- Dongguan Songshan Lake Tungwah Hospital
- Dongguan Guangming Ophthalmic Hospital
The Greater Bay Area consists of two SARs (Hong Kong and Macao) and nine Pearl River Delta municipalities in the Guangdong Province. China aims to build the Greater Bay Area into a hub of global technological innovation and an important source of emerging industries. For the past years, more and more medical institutions owned or managed by Hong Kong enterprises have been providing healthcare services in the Greater Bay Area.
Cisema has the capability to help you comply with Hong Kong MDACS requirements.